Next 10 |
2024-03-21 15:23:03 ET 111, Inc. (YI) Q4 2023 Earnings Conference Call March 21, 2024 07:30 ET Company Participants Junling Liu - Co-Founder, Chairman & Chief Executive Officer Luke Chen - Chief Financial Officer of 111's Major Subsidiary Conference Call Pa...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
2024-03-21 05:10:29 ET More on 111 Financial information for 111 Read the full article on Seeking Alpha For further details see: 111 Non-GAAP EPADS of -$0.08, revenue of $578.7M
111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results PR Newswire SHANGHAI , March 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting p...
111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow PR Newswire SHANGHAI , March 1, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company com...
111 Announces Receipt of Withdrawal of Going Private Proposal PR Newswire SHANGHAI , Feb. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with ...
2023-11-30 15:56:06 ET 111, Inc. (YI) Q3 2023 Results Conference Call November 30, 2023 07:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and CEO Luke Chen - CFO of 111's Major Subsidiary Haihui Wa...
Veradigm Inc. (MDRX) is expected to report $0.17 for Q3 2023 Aperam SA New York Shares (APEMY) is expected to report for Q3 2023 HTG Molecular Diagnostics Inc. (HTGMQ) is expected to report for Q3 2023 Enel Spa ADR (ENLAY) is expected to report for Q3 2023 Firm Capital Property Tr...
111 Inc. (YI) is expected to report for quarter end 2023-09-30
2023-11-30 02:24:10 ET More on 111 Financial information for 111 For further details see: 111 Non-GAAP EPADS of -$0.12, revenue of $502.4M
News, Short Squeeze, Breakout and More Instantly...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results PR Newswire SHANGHAI , March 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting p...
111 to Announce Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results- Conference Call to Follow PR Newswire SHANGHAI , March 1, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company com...